HER2 testing in gastric cancer: An update

被引：201
|
作者：
Abrahao-Machado, Lucas Faria [1 ]
Scapulatempo-Neto, Cristovam [1 ]
机构：
[1] Barretos Canc Hosp, Dept Pathol, Rua Antenor Duarte Villela 1331, BR-14784400 Barretos, SP, Brazil
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2016年 / 22卷 / 19期
关键词：
Human epidermal growth factor receptor 2 testing; Gastric cancer; Immunohistochemistry; Scoring system; Trastuzumab; IN-SITU HYBRIDIZATION; GENE AMPLIFICATION; HELICOBACTER-PYLORI; SCORING SYSTEM; EXPRESSION; FISH; VALIDATION; PROGNOSIS; CARCINOMA; OVEREXPRESSION;
D O I：
10.3748/wjg.v22.i19.4619
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Human epidermal growth factor receptor 2 (HER2) overexpression is increasingly recognized as a frequent molecular abnormality in gastric and gastroesophageal cancer. With the recent introduction of HER2 molecular targeted therapy for patients with advanced gastric cancer, determination of HER2 status is crucial in order to select patients who may benefit from this treatment. This paper provides an update on our knowledge of HER2 in gastric and gastroesophageal cancer, including the prognostic relevance of HER2, the key differences between HER2 protein expression interpretation in breast and gastric cancer, the detection methods and the immunohistochemistry scoring system.
引用
收藏
页码：4619 / 4625
页数：7
相关论文
共 50 条
  • [31] HER-2 amplification is highly homogenous in gastric cancer
    Marx, Andreas H.
    Tharun, Lars
    Muth, Johanna
    Dancau, Ana-Maria
    Simon, Ronald
    Yekebas, Emre
    Kaifi, Jussuf T.
    Mirlacher, Martina
    Bruemmendorf, Tim H.
    Bokemeyer, Carsten
    Izbicki, Jakob R.
    Sauter, Guide
    HUMAN PATHOLOGY, 2009, 40 (06) : 769 - 777
  • [32] Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma
    Gomez-Martin, Carlos
    Concha, Angel
    Mara Corominas, Jose
    Garcia-Caballero, Tomas
    Garcia-Garcia, Elena
    Iglesias, Mar
    Antonio Lopez, Jose
    Ramon y Cajal, Santiago
    Rojo, Federico
    Palacios, Jose
    Vera-Sempere, Francisco
    Aranda, Enrique
    Colomer, Ramon
    Garcia-Alfonso, Pilar
    Garrido, Pilar
    Rivera, Fernando
    Lopez-Rios, Fernando
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (09): : 636 - 651
  • [33] Clinical significance of assessing Her2/neu expression in gastric cancer with dual tumor tissue paraffin blocks
    Ge, Xiaowen
    Wang, Haixing
    Zeng, Haiying
    Jin, Xuejuan
    Sujie, Akesu
    Xu, Chen
    Liu, Yalan
    Huang, Jie
    Ji, Yuan
    Tan, Yunshan
    Liu, Tianshu
    Hou, Yingyong
    Qin, Jing
    Sun, Yihong
    Qin, Xinyu
    HUMAN PATHOLOGY, 2015, 46 (06) : 850 - 857
  • [34] HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature
    Jorgensen, Jan Trost
    Hersom, Maria
    JOURNAL OF CANCER, 2012, 3 : 137 - 144
  • [35] Changes in HER2 Expression and Amplification Status Following Preoperative Chemotherapy for Gastric Cancer
    Shu, Sei
    Iimori, Makoto
    Nakanishi, Ryota
    Jogo, Tomoko
    Saeki, Hiroshi
    Oki, Eiji
    Maehara, Yoshihiko
    IN VIVO, 2018, 32 (06): : 1491 - 1498
  • [36] HER2 testing in gastric cancer - results of a German expert meeting
    Lordick, F.
    Al-Batran, S. E.
    Hofheinz, R. D.
    Lorenzen, S.
    Thuss-Patience, P.
    Baretton, G. B.
    Dietel, M.
    Gaiser, T.
    Kirchner, T.
    Kreipe, H. H.
    Quaas, A.
    Roecken, C.
    Rueschoff, J.
    Tannapfel, A.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (08): : 791 - 796
  • [37] HER2 testing in gastric cancer: results of a German expert meeting
    Lordick, Florian
    Al-Batran, Salah-Eddin
    Dietel, Manfred
    Gaiser, Timo
    Hofheinz, Ralf-Dieter
    Kirchner, Thomas
    Kreipe, Hans H.
    Lorenzen, Sylvie
    Moehler, Markus
    Quaas, Alexander
    Roecken, Christoph
    Rueschoff, Josef
    Tannapfel, Andrea
    Thuss-Patience, Peter
    Baretton, Gustavo
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (05) : 835 - 841
  • [38] HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer
    Gomez-Martin, Carlos
    Garralda, Elena
    Jose Echarri, M.
    Ballesteros, Anabel
    Arcediano, Alberto
    Luis Rodriguez-Peralto, Jose
    Hidalgo, Manuel
    Lopez-Rios, Fernando
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (08) : 751 - 757
  • [39] Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas
    Wang, Xin-Yu
    Zheng, Zhi-Xue
    Sun, Yu
    Bai, Yan-Hua
    Shi, Yun-Fei
    Zhou, Li-Xin
    Yao, Yun-Feng
    Wu, Ai-Wen
    Cao, Deng-Feng
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (04) : 335 - 347
  • [40] Serum HER2 Is a Potential Surrogate for Tissue HER2 Status in Gastric Cancer: A Systematic Review and Meta-Analysis
    Zhang, Kecheng
    Cui, Jianxin
    Xi, Hongqing
    Bian, Shibo
    Ma, Liangang
    Shen, Weisong
    Li, Jiyang
    Wang, Ning
    Wei, Bo
    Chen, Lin
    PLOS ONE, 2015, 10 (08):
12345